|
|
|
Elements’ important ranking of China drug
safety management system: applying the non-structural fuzzy group
decision method |
| Xiaoping ZHENG,Xiaocui WANG,Tingkuan ZHONG, |
| Institute of Safety Management,
Beijing University of Chemical Technology, Beijing 100029, China; |
|
|
|
|
Abstract Drug safety management is an important issue in China drug management system and attracts great attentions from the whole society. In order to reduce drug incident, this study discusses some important elements associated with China drug safety management system and analyzes the data collected by questionnaires. Besides, a methodology for rating the important elements is described and applied. The non-structural fuzzy group decision method not only considers the insufficient precise information but also combines the opinions of different kinds of respondents in China’s four municipalities. The results indicate that the sample systems are the most important in these important elements, and the order of importance is sampling systems, licensing systems, traceability systems, transaction models, pharmacovigilance and emergence management. This study not only points out the important ranking of the pivotal elements in China drug safety management but also gives some specific proposals about how to enhance drug safety management in China.
|
|
Issue Date: 05 September 2010
|
|
|
Grant I. UK to track US on drug traceability. Infosecurity Today, 2006, 3(5): 6–8
doi: 10.1016/S1742-6847(06)70449-9
|
|
Abraham J. Transnational industrial power, the medicalprofession and the regulatory state: adverse drug reactions and thecrisis over the safety of Halcion in the Netherlands and the UK. Soc Sci Med, 2002, 55:1671–1690
doi: 10.1016/S0277-9536(02)00160-0
|
|
McEwen J. Risk management from an Asian/Pacific Rim regulatoryperspective. Drug Safety, 2004, 27(8): 491–497
doi: 10.2165/00002018-200427080-00002
|
|
Yee S K, Chu S S, Xu Y M, Choo P L. Regulatory control of Chinese Proprietary Medicines in Singapore. Health Poli, 2005, 71(2): 133–149
doi: 10.1016/j.healthpol.2003.09.013
|
|
Harlanda C, Walkera H. A strategic case for e-adoption in healthcare supply chains. Int J Inf Manage, 2006, 26: 290–301
doi: 10.1016/j.ijinfomgt.2006.03.010
|
|
Chen S Y. Engineering fuzzy set theory and application. Beijing: State Security Industry Press, 1998, 59–79
|
|
Olcer A I, Odabasi A Y. A new fuzzy attributive group decision making methodology and itsapplication to propulsion/manoeuvring system selection problem. Eur J Oper, 2005, 166: 93–114
doi: 10.1016/j.ejor.2004.02.010
|
|
Tam C M, Tong T K L, Chiu G W C. Comparing non-structural fuzzy decisionsupport system and analytical hierarchy process in decision-makingfor construction problems. Eur J Oper, 2006, 174: 1317–1324
doi: 10.1016/j.ejor.2005.03.013
|
|
Dong H, Bogg L, Rehnberg C, Diwan V. Drug policy in China: pharmaceutical distribution in rural areas. Soc Sci Med, 1999, 48: 777–786
doi: 10.1016/S0277-9536(98)00414-6
|
|
Bond C, Hannaford P. Issues related to monitoring the safetyof Over-The-Counter (OTC) medicines. Drug Safety, 2003, 26(15): 1065–1074
doi: 10.2165/00002018-200326150-00001
|
|
Starbird S A, Amanor-Boadu V. Do inspection and traceability provide incentives for food safety? Journal of Agricultural and Resource Economics, 2006, 3l(1): 14–26
|
|
Boxtel C J V, Wang G. Some observations on pharmacoepidemiology in Europe. The Netherlands Journal of Medicine, 1997, 51(6): 205–212
doi: 10.1016/S0300-2977(97)00054-5
|
|
Almenoff J S. Innovations for the future of pharmacovigilance. Drug Safety, 2007, 30(7): 631–633
doi: 10.2165/00002018-200730070-00013
|
|
Wilson J, Oyola-Yemaiel A. The evolution of emergency management and the advancement towards a professionin the United States and Florida. Safety Sci, 2001, 39: 117–131
doi: 10.1016/S0925-7535(01)00031-5
|
|
Tam C M, Tong T K L, Chiu G C W, Fung I W H. Non-structural fuzzy decision support system for evaluation of constructionsafety management system. Int J Proj Manage, 2002, 20: 303–313
doi: 10.1016/S0263-7863(00)00055-7
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
